Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 2, 2016, Pages 387-394

  Badia, Roger ^a   Angulo, Guillem ^a   Riveira Muñoz, Eva ^a   Pujantell, Maria ^a   Puig, Teresa ^a   Ramirez, Cristina ^a   Torres Torronteras, Javier ^a   Martí, Ramón ^a   Pauls, Eduardo ^a   Clotet, Bonaventura ^a   Ballana, Ester ^a   Esté, José A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLIN DEPENDENT KINASE 2; DEOXYRIBONUCLEOTIDE; PALBOCICLIB; PROTEIN DERIVATIVE; STERILE ALPHA MOTIF AND HISTIDINE ASPARTATE DOMAIN CONTAINING PROTEIN 1; UNCLASSIFIED DRUG; ZIDOVUDINE; CDK6 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 6; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SAMHD1 PROTEIN, HUMAN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 6; HERPESVIRUS 1, HUMAN; HUMANS; MACROPHAGES; MONOMERIC GTP-BINDING PROTEINS; PIPERAZINES; PYRIDINES; VIRUS REPLICATION;

EID: 84959911305     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv363     Document Type: Article

References (44)

1. Ballana E, Esté JA. SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction. Trends Microbiol 2015; doi:10.1016/j.tim.2015.08.002.
2. Lahouassa H, Daddacha W, Hofmann H et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012; 13: 223-8.
3. Pauls E, Ballana E, Esté JA. Nucleotide embargo by SAMHD1: a strategy to block retroviral infection. Antiviral Res 2013; 97: 180-2.
4. Seamon KJ, Sun Z, Shlyakhtenko LS et al. SAMHD1 is a single-stranded nucleic acid binding protein with no active site-associated nuclease activity. Nucleic Acids Res 2015; 43: 6486-99.
5. Rehwinkel J, Maelfait J, Bridgeman A et al. SAMHD1-dependent retroviral control and escape in mice. EMBO J 2013; 32: 2454-62.
6. Rehwinkel J. Mouse knockout models for HIV-1 restriction factors. Cell Mol Life Sci 2014; 71: 3749-66.
7. Shingai M, Welbourn S, Brenchley JM et al. The expression of functional Vpx during pathogenic SIVmac infections of rhesus macaques suppresses SAMHD1 in CD4+ memory T cells. PLoS Pathog 2015; 11: e1004928.
8. Ruffin N, Brezar V, Ayinde D et al. Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1. AIDS 2015; 29: 519-30.
9. Riveira-Munoz E, Ruiz A, Pauls E et al. Increased expression of SAMHD1 in a subset of HIV-1 elite controllers. J Antimicrob Chemother 2014; 69: 3057-60.
10. Buchanan EL, McAlexander MA, Witwer KW. SAMHD1 expression in blood cells of HIV-1 elite suppressors and viraemic progressors. J Antimicrob Chemother 2015; 70: 954-6.
11. Pauls E, Badia R, Torres-Torronteras J et al. Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile a motif and HD domain-containing protein-1 (SAMHD1) activity. AIDS 2014; 28: 2213-22.
12. Pauls E, Ruiz A, Badia R et al. Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells. J Immunol 2014; 193: 1988-97.
13. Ruiz A, Pauls E, Badia R et al. Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages. Cell Cycle 2015; 14: 1657-65.
14. Yan J, Hao C, DeLucia M et al. CyclinA2-cyclin-dependent kinase regulates SAMHD1 protein phosphohydrolase domain. J Biol Chem 2015; 290: 13279-92.
15. Pauls E, Ruiz A, Riveira-Muñoz E et al. p21 regulates the HIV-1 restriction factor SAMHD1. Proc Natl Acad Sci USA 2014; 111: E1322-4.
16. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9: 153-66.
17. St Gelais C, de Silva S, Hach JC et al. Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1. J Virol 2014; 88: 5834-44.
18. Cribier A, Descours B, Valadao AL et al. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep 2013; 3: 1036-43.
19. Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002; 2: 910-7.
20. Sherr CJ, Roberts JM. Living with or without cyclins and cyclindependent kinases. Genes Dev 2004; 18: 2699-711.
21. Leonard JP, LaCasce AS, Smith MR. et al. Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood 2012; 119: 4597-607.
22. U.S. Department of Health and Human Services. FDA Information on Drugs. Approved Drugs. http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm432886.htm.
23. Kim ET, White TE, Brandariz-Nunez A et al. SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication. J Virol 2013; 87: 12949-56.
24. Hollenbaugh JA, Gee P, Baker J et al. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog 2013; 9: e1003481.
25. Schang LM. Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother 2002; 50: 779-92.
26. Yamamoto M, Onogi H, Kii I et al. CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses. J Clin Invest 2014; 124: 3479-88.
27. Schang LM, Bantly A, Knockaert M et al. Pharmacological cyclindependent kinase inhibitors inhibit replication of wild-type and drugresistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins. J Virol 2002; 76: 7874-82.
28. Badia R, Riveira-Muñoz E, Clotet B et al. Gene editing using a zinc-finger nuclease mimicking the CCR5D32 mutation induces resistance to CCR5-using HIV-1. J Antimicrob Chemother 2014; 69: 1755-99.
29. Badia R, Grau J, Riveira-Muñoz E et al. The thioacetate-v(g-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent. Antiviral Res 2015; 123: 62-9.
30. Neyts J, Reymen D, Letourneur D et al. Differential antiviral activity of derivatized dextrans. Biochem Pharmacol 1995; 50: 743-51.
31. Ballana E, Badia R, Terradas G et al. SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors. Antimicrob Agents Chemother 2014; 58: 4804-13.
32. Aduma PJ, Gupta SV, Stuart AL et al. Deoxyribonucleoside triphosphate pools of herpes simplex virus infected cells: the influence of selective antiherpes agents and the role of the deaminase pathway. Biochem Cell Biol 1991; 69: 409-14.
33. Franzolin E, Pontarin G, Rampazzo C et al. The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. Proc Natl Acad Sci USA 2013; 110: 14272-7.
34. Clifford R, Louis T, Robbe P et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 2014; 123: 1021-31.
35. Choi J, Ryoo J, Oh C et al. SAMHD1 specifically restricts retroviruses through its RNase activity. Retrovirology 2015; 12: 46.
36. Ryoo J, Choi J, Oh C et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med 2014; 20: 936-41.
37. Allouch A, David A, Amie SM et al. p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway. Proc Natl Acad Sci USA 2013; 110: E3997-4006.
38. Amie SM, Noble E, Kim B. Intracellular nucleotide levels and the control of retroviral infections. Virology 2013; 436: 247-54.
39. Souza TM, De Souza MC, Ferreira VF et al. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1, 4-dihydro-4-oxo-1-(b-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone. Antiviral Res 2008; 77: 20-7.
40. Lembo D, Brune W. Tinkering with a viral ribonucleotide reductase. Trends Biochem Sci 2008; 34: 25-32.
41. Gandhi VV, Samuels DC. A review comparing deoxyribonucleoside triphosphate (dNTP) concentrations in the mitochondrial and cytoplasmic compartments of normal and transformed cells. Nucleosides Nucleotides Nucleic Acids 2011; 30: 317-39.
42. Lund TJ, Cavanaugh NA, Joubert N et al. B family DNA polymerases asymmetrically recognize pyrimidines and purines. Biochemistry 2011; 50: 7243-50.
43. 1 entry in quiescent cells. Virology 2000; 267: 335-49.
44. Heng MCY, Heng SY, Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 1994; 343: 255-8.